Haemoglobin oxygen saturation, leucocyte count and lactate dehydrogenase are predictors of elevated cerebral blood flow velocity in Nigerian children with sickle cell anaemia

References

• Ohene-Frempong K, Weiner SJ, Sleeper LA, et al. Cooperative study of sickle cell disease: cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood. 1998;91:288–294.
   PubMed Web of Science ®Google Scholar
• Oniyangi O, Ahmed P, Otuneye OT, et al. Strokes in children with sickle cell disease at the National Hospital, Abuja, Nigeria. Niger J Paediatr. 2013;40:158–164.
   Google Scholar
• Kehinde MO, Temiye EO, Danesi MA. Neurological complications of sickle cell anaemia in Nigerian Africans – a case-control study. J Nat Med Assoc. 2008;100:394–400.10.1016/S0027-9684(15)31271-2
   PubMed Web of Science ®Google Scholar
• George IO, Frank-Briggs AI. Stroke in Nigerian children with sickle cell anaemia. J Public Health Epidemiol. 2011;3:407–409.
   Google Scholar
• Lagunju IA, Brown BJ. Adverse neurological outcomes in Nigerian children with sickle cell disease. Int J Haematol. 2012;96:710–718.10.1007/s12185-012-1204-9
   PubMed Web of Science ®Google Scholar
• Adams RJ, McKie V, Nichols F, et al. The use of transcranial Doppler ultrasonography to predict stroke in sickle cell disease. N Engl J Med. 1992;326:605–610.10.1056/NEJM199202273260905
   PubMed Web of Science ®Google Scholar
• Brousse V, Kossorotoff M, Montalembert M. How I manage cerebral vasculopathy in children with sickle cell disease. Br J Haematol. 2015;170:615–625.10.1111/bjh.2015.170.issue-5
   PubMed Web of Science ®Google Scholar
• Adams RJ, McKie VC, Hsu L, et al. Prevention of a first stroke by transfusions in children with sickle cell anaemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med. 1998;339:5–11.10.1056/NEJM199807023390102
   PubMed Web of Science ®Google Scholar
• Kwiatkowski JL, Hunter JV, Smith-Whitley K, et al. Transcranial Doppler ultrasonography in siblings with sickle cell disease. Br J Haematol. 2003;121:932–937.10.1046/j.1365-2141.2003.04276.x
   PubMed Web of Science ®Google Scholar
• Soyebi K, Adeyemo T, Ojewunmi O, et al. Capacity building and stroke risk assessment in Nigerian children with sickle cell anaemia. Pediatr Blood Cancer. 2014;61:2263–2266.10.1002/pbc.v61.12
   PubMed Web of Science ®Google Scholar
• Adams RJ, McKie VC, Carl EM, et al. Long-term stroke risk in children with sickle cell disease screened with transcranial doppler. Ann Neurol. 1997;42:699–704.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Sickle Cell Anaemia. Fifty-ninth World Health Assembly; 2006. Available from: http://apps.who.int/gb/archive/pdf_files/WHA59/A59_9-en.pdf
   Google Scholar
• Deane CR, Goss D, O’Driscoll S, et al. Transcranial Doppler scanning and the assessment of stroke risk in children with haemoglobin sickle cell disease. Arch Dis Child. 2008;93:138–141.10.1136/adc.2007.125799
   PubMed Web of Science ®Google Scholar
• Zétola VF. Role of TCD in sickle cell anaemia. Perspect Med. 2012;1:265–268.10.1016/j.permed.2012.03.016
   Google Scholar
• Bulas DI, Jones A, Seibert JJ, et al. Transcranial Doppler (TCD) screening for stroke prevention in sickle cell anemia: pitfalls in technique variation. Pediatr Radiol. 2000;30:733–738.10.1007/s002470000317
   PubMed Web of Science ®Google Scholar
• Purkayastha S, Sorond F. Transcranial Doppler ultrasound: technique and application. Semin Neurol. 2012;32:411–420.
   PubMed Web of Science ®Google Scholar
• Solovey A, Lin Y, Browne P, et al. Circulating activated endothelial cells in sickle cell anemia. N Engl J Med. 1997;337:1584–1590.10.1056/NEJM199711273372203
   PubMed Web of Science ®Google Scholar
• Kato GJ, Hebbel RP, Steinberg MH, et al. Vasculopathy in sickle cell disease: biology, pathophysiology, genetics, translational medicine, and new research directions. Am J Hematol. 2009;84:618–625.10.1002/ajh.v84:9
   PubMedGoogle Scholar
• Gladwin MT, Sachdev V, Jison ML, et al. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N Engl J Med. 2004;350:886–895.10.1056/NEJMoa035477
   PubMed Web of Science ®Google Scholar
• Lagunju I, Sodeinde O, Telfer P. Prevalence of transcranial Doppler abnormalities in Nigerian children with sickle cell disease. Am J Hematol. 2012;87:544–547.10.1002/ajh.v87.5
   PubMed Web of Science ®Google Scholar
• Kirkham FJ, Hewes DK, Prengler M, et al. Nocturnal hypoxaemia and central nervous-system events in sickle-cell disease. Lancet. 2001;357:1656–1659.10.1016/S0140-6736(00)04821-2
   PubMed Web of Science ®Google Scholar
• Adams GT, Sneider H, McKie VC, et al. Genetic risk factors for cerebrovascular disease in children with sickle cell disease: design of a case-control association study and genomewide screen. BMC Med Genet. 2003;4:6. doi:10.1186/1471-2350-4-6.
   PubMedGoogle Scholar
• Quinn CT, Sargent JW. Daytime steady state haemoglobin desaturation is a risk factor for overt stroke in children with sickle cell anaemia. Br J Haematol. 2008;140:336–339.10.1111/bjh.2008.140.issue-3
   PubMed Web of Science ®Google Scholar
• Makani J, Kirkham FJ, Komba A, et al. Risk factors for high cerebral blood flow velocity and death in Kenyan children with Sickle Cell Anaemia: role of haemoglobin oxygen saturation and febrile illness. Br J Haematol. 2009;145:529–532.10.1111/bjh.2009.145.issue-4
   PubMed Web of Science ®Google Scholar
• Hsu LL, Miller ST, Wright E, et al. Alpha thalassemia is associated with decreased risk of abnormal transcranial doppler ultrasonography in children with sickle cell anemia. J Pediatr Hematol Oncol. 2003;25:622–628.10.1097/00043426-200308000-00007
   PubMed Web of Science ®Google Scholar
• Akinola NO, Stevens SME, Franklin IM, et al. Subclinical ischaemic episodes during the steady state of sickle cell anaemia. J Clin Pathol. 1992;45:902–906.10.1136/jcp.45.10.902
   PubMed Web of Science ®Google Scholar
• Okpala I. The intriguing contribution of white blood cells to sickle cell disease – a red cell disorder. Blood Rev. 2004;18:65–73.10.1016/S0268-960X(03)00037-7
   PubMed Web of Science ®Google Scholar
• Setty BN, Stuart MJ, Dampier C, et al. Hypoxaemia in sickle cell disease: biomarker modulation and relevance to pathophysiology. Lancet. 2003;362:1450–1455.10.1016/S0140-6736(03)14689-2
   PubMed Web of Science ®Google Scholar
• Adams RJ, Kutlar A, McKie V, et al. Alpha thalassemia and stroke risk in sickle cell anemia. Am J Hematol. 1994;45:279–282.10.1002/(ISSN)1096-8652
   PubMed Web of Science ®Google Scholar
• Bernaudin F, Verlhac S, Chevret S, et al. G6PD deficiency, absence of alpha-thalassemia, and hemolytic rate at baseline are significant independent risk factors for abnormally high cerebral velocities in patients with sickle cell anemia. Blood. 2008;112:4314–4317.10.1182/blood-2008-03-143891
   PubMed Web of Science ®Google Scholar
• Steinberg MH, Embury SH. Alpha-thalassemia in blacks: genetic and clinical aspects and interactions with the sickle hemoglobin gene. Blood. 1986;68:985–990.
   PubMed Web of Science ®Google Scholar
• Cox SE, Makani J, Newton CR, et al. Hematological and genetic predictors of daytime hemoglobin saturation in Tanzanian children with and without sickle cell anemia. ISRN Hematol. 2013;472909.
   PubMedGoogle Scholar
• Rees DC, Lambert C, Cooper E, et al. Glucose 6 phosphate dehydrogenase deficiency is not associated with cerebrovascular disease in children with sickle cell anemia. Blood. 2009;114:742–743.10.1182/blood-2009-04-216861
   PubMed Web of Science ®Google Scholar
• Kato GJ, McGowan V, Machado RF, et al. Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease. Blood. 2006;107:2279–2285.10.1182/blood-2005-06-2373
   PubMed Web of Science ®Google Scholar
• Rother RP, Bell L, Hillmen P, et al. The clinical sequelae of intravascular haemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA. 2005;293:1653–1662.10.1001/jama.293.13.1653
   PubMed Web of Science ®Google Scholar
• Wood KC, Hsu LL, Gladwin MT. Sickle cell anaemia vasculopathy: a state of nitric oxide resistance. Free Radic Biol Med. 2008;44:1506–1528.10.1016/j.freeradbiomed.2008.01.008
   PubMed Web of Science ®Google Scholar
• Kim-Shapiro DB, Gladwin MT. Pitfalls in measuring NO bioavailability using NOx. Nitric Oxide. 2015;44:1–2.10.1016/j.niox.2014.10.003
   PubMed Web of Science ®Google Scholar
• Stojanovic KS, Steichen O, Lefevre G, et al. High lactate dehydrogenase levels at admission for painful vaso-occlusive crisis is associated with severe outcome in adult SCD patients. Clin Biochem. 2012;45:1578–1582.10.1016/j.clinbiochem.2012.07.114
   PubMed Web of Science ®Google Scholar
• O’Driscoll S, Height SE, Dick MC, et al. Serum lactate dehydrogenase activity as a biomarker in children with sickle cell disease. Br J Haematol. 2007;140:206–209.
   PubMed Web of Science ®Google Scholar